Medical marijuana: Florida parents fight to help children suffering with seizures

Bradenton Herald - 4 days ago
These families are faced with...

Ann Arbor area business briefs: University Bank and Retirement Income Solutions - 1 week ago
University of Michigan experts in...

100 hospitals with great neurosurgery and spine programs | 2014

Becker's Hospital Review - 2 weeks ago
based Mayo Clinic, allowing...

Letter: Previous letter renders several opinions without facts

Elburn Herald - 1 week ago
As testified in trial, while Fox...

Obama calls for dismantling IS 'network of death' - 1 month ago
The president's remarks came...

The (seemingly) best stuff from the Carmel International Film Festival.

Monterey County Weekly - 2 weeks ago
Hilary Swank plays a young woman...

Why Brittany Maynard's choice to die is not personal or private

Washington Post - 2 weeks ago
Already, her decision has...

Gorham saddles four winners on Michigan Sire Stakes card at Hazel Park

Daily Racing Form - 1 month ago
Al's Prayer added a second...

Ecclestone on US Rare Earths – Heading Them Off at the Pass?

InvestorIntel - 3 weeks ago
Portions of the extracted rare...

News via Google. See more news matching 'als expanded access'


Expanded Access

Bringing Research and Patients Together

Our Expanded Access platform is meant to do two things:

  1. Empower patients with access to new treatments that are in clinical research.
  2. Empower further research with clinical data from those patients.

For someone with a quick-killer disease, participating in clinical research may be the only way to access a new medicine that might help him live longer.  He may be willing to accept some uncertainty, considering the alternative.  So for patients, there’s a lot of overlap between treatment exploration and research.

But what about patients who cannot get into clinical trials?  Can they still take part in research and explore investigational treatment?

Yes, they can, but only through what are called Expanded Access programs (EAPs).  These are meant to include a much broader group of patients than traditional clinical trials, sometimes exclusively those patients who don’t meet clinical trial enrollment criteria or who otherwise cannot get into trials.

ALS-ETF is bringing a new kind of Expanded Access to the ALS community, to make a groundbreaking impact in the treatment landscape for patients as well as the research that’s powered by patient data.

Learn more about Expanded Access programs here.

Learn more about our research goals here.